[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Drug Eluting Stents (DES) Market Report 2016

November 2016 | 115 pages | ID: U4975A31513EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drug Eluting Stents (DES)

Revenue, means the sales value of Drug Eluting Stents (DES)

This report studies sales (consumption) of Drug Eluting Stents (DES) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Abbott Vascular
  • Advantec Vascular
  • B.Braun Melsengen AG
  • Biosensors
  • Biotronik
  • Blue Medical
  • Boston Scientific
  • DISA Vascular
  • Essen
  • Medtronic Vascular
  • MicroPort Medical
  • MIV Therapeutics
  • Orbusneich
  • Promed Medical
  • Relisys Medical
  • Reva Medical
  • Sahajanand
  • Sino Medical
  • Sorin
  • Terumo Medical
  • Translumina
  • Vascular Concepts
  • JW Medical Systems
  • Kinhely
  • Lepu Medical
  • Medfavour Medical
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Cobalt-chromium alloy Stents
  • Magnesium alloy Stents
  • Tyrosine polycarbonate Stents
  • Nitinol Stents
  • Platinum chromium alloy Stents
  • Stainless steel Stents
  • Other Materials
Split by applications, this report focuses on sales, market share and growth rate of Drug Eluting Stents (DES) in each application, can be divided into
  • Coronary Heart Disease
  • Others
  • Application 3
United States Drug Eluting Stents (DES) Market Report 2016

1 DRUG ELUTING STENTS (DES) OVERVIEW

1.1 Product Overview and Scope of Drug Eluting Stents (DES)
1.2 Classification of Drug Eluting Stents (DES)
  1.2.1 Cobalt-chromium alloy Stents
  1.2.2 Magnesium alloy Stents
  1.2.3 Tyrosine polycarbonate Stents
  1.2.4 Nitinol Stents
  1.2.5 Platinum chromium alloy Stents
  1.2.6 Stainless steel Stents
  1.2.7 Other Materials
1.3 Application of Drug Eluting Stents (DES)
  1.3.1 Coronary Heart Disease
  1.3.2 Others
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drug Eluting Stents (DES) (2011-2021)
  1.4.1 United States Drug Eluting Stents (DES) Sales and Growth Rate (2011-2021)
  1.4.2 United States Drug Eluting Stents (DES) Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUG ELUTING STENTS (DES) COMPETITION BY MANUFACTURERS

2.1 United States Drug Eluting Stents (DES) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drug Eluting Stents (DES) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drug Eluting Stents (DES) Average Price by Manufactures (2015 and 2016)
2.4 Drug Eluting Stents (DES) Market Competitive Situation and Trends
  2.4.1 Drug Eluting Stents (DES) Market Concentration Rate
  2.4.2 Drug Eluting Stents (DES) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUG ELUTING STENTS (DES) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Drug Eluting Stents (DES) Sales and Market Share by Type (2011-2016)
3.2 United States Drug Eluting Stents (DES) Revenue and Market Share by Type (2011-2016)
3.3 United States Drug Eluting Stents (DES) Price by Type (2011-2016)
3.4 United States Drug Eluting Stents (DES) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRUG ELUTING STENTS (DES) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Drug Eluting Stents (DES) Sales and Market Share by Application (2011-2016)
4.2 United States Drug Eluting Stents (DES) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRUG ELUTING STENTS (DES) MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Vascular
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Advantec Vascular
  5.2.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 B.Braun Melsengen AG
  5.3.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Biosensors
  5.4.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Biosensors Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Biotronik
  5.5.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Biotronik Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Blue Medical
  5.6.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Blue Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Boston Scientific
  5.7.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Boston Scientific Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 DISA Vascular
  5.8.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 DISA Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Essen
  5.9.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Essen Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Medtronic Vascular
  5.10.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 MicroPort Medical
5.12 MIV Therapeutics
5.13 Orbusneich
5.14 Promed Medical
5.15 Relisys Medical
5.16 Reva Medical
5.17 Sahajanand
5.18 Sino Medical
5.19 Sorin
5.20 Terumo Medical
5.21 Translumina
5.22 Vascular Concepts
5.23 JW Medical Systems
5.24 Kinhely
5.25 Lepu Medical
5.26 Medfavour Medical

6 DRUG ELUTING STENTS (DES) MANUFACTURING COST ANALYSIS

6.1 Drug Eluting Stents (DES) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drug Eluting Stents (DES)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Drug Eluting Stents (DES) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRUG ELUTING STENTS (DES) MARKET FORECAST (2016-2021)

10.1 United States Drug Eluting Stents (DES) Sales, Revenue Forecast (2016-2021)
10.2 United States Drug Eluting Stents (DES) Sales Forecast by Type (2016-2021)
10.3 United States Drug Eluting Stents (DES) Sales Forecast by Application (2016-2021)
10.4 Drug Eluting Stents (DES) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Drug Eluting Stents (DES)
Table Classification of Drug Eluting Stents (DES)
Figure United States Sales Market Share of Drug Eluting Stents (DES) by Type in 2015
Figure Cobalt-chromium alloy Stents Picture
Figure Magnesium alloy Stents Picture
Figure Tyrosine polycarbonate Stents Picture
Figure Nitinol Stents Picture
Figure Platinum chromium alloy Stents Picture
Figure Stainless steel Stents Picture
Figure Other Materials Picture
Table Application of Drug Eluting Stents (DES)
Figure United States Sales Market Share of Drug Eluting Stents (DES) by Application in 2015
Figure Coronary Heart Disease Examples
Figure Others Examples
Figure United States Drug Eluting Stents (DES) Sales and Growth Rate (2011-2021)
Figure United States Drug Eluting Stents (DES) Revenue and Growth Rate (2011-2021)
Table United States Drug Eluting Stents (DES) Sales of Key Manufacturers (2015 and 2016)
Table United States Drug Eluting Stents (DES) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drug Eluting Stents (DES) Sales Share by Manufacturers
Figure 2016 Drug Eluting Stents (DES) Sales Share by Manufacturers
Table United States Drug Eluting Stents (DES) Revenue by Manufacturers (2015 and 2016)
Table United States Drug Eluting Stents (DES) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drug Eluting Stents (DES) Revenue Share by Manufacturers
Table 2016 United States Drug Eluting Stents (DES) Revenue Share by Manufacturers
Table United States Market Drug Eluting Stents (DES) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drug Eluting Stents (DES) Average Price of Key Manufacturers in 2015
Figure Drug Eluting Stents (DES) Market Share of Top 3 Manufacturers
Figure Drug Eluting Stents (DES) Market Share of Top 5 Manufacturers
Table United States Drug Eluting Stents (DES) Sales by Type (2011-2016)
Table United States Drug Eluting Stents (DES) Sales Share by Type (2011-2016)
Figure United States Drug Eluting Stents (DES) Sales Market Share by Type in 2015
Table United States Drug Eluting Stents (DES) Revenue and Market Share by Type (2011-2016)
Table United States Drug Eluting Stents (DES) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug Eluting Stents (DES) by Type (2011-2016)
Table United States Drug Eluting Stents (DES) Price by Type (2011-2016)
Figure United States Drug Eluting Stents (DES) Sales Growth Rate by Type (2011-2016)
Table United States Drug Eluting Stents (DES) Sales by Application (2011-2016)
Table United States Drug Eluting Stents (DES) Sales Market Share by Application (2011-2016)
Figure United States Drug Eluting Stents (DES) Sales Market Share by Application in 2015
Table United States Drug Eluting Stents (DES) Sales Growth Rate by Application (2011-2016)
Figure United States Drug Eluting Stents (DES) Sales Growth Rate by Application (2011-2016)
Table Abbott Vascular Basic Information List
Table Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Vascular Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Advantec Vascular Basic Information List
Table Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantec Vascular Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table B.Braun Melsengen AG Basic Information List
Table B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table B.Braun Melsengen AG Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Biosensors Basic Information List
Table Biosensors Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosensors Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Biotronik Basic Information List
Table Biotronik Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotronik Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Blue Medical Basic Information List
Table Blue Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Blue Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Boston Scientific Basic Information List
Table Boston Scientific Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table DISA Vascular Basic Information List
Table DISA Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table DISA Vascular Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Essen Basic Information List
Table Essen Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Essen Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Medtronic Vascular Basic Information List
Table Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic Vascular Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table MicroPort Medical Basic Information List
Table MicroPort Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table MicroPort Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table MIV Therapeutics Basic Information List
Table MIV Therapeutics Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table MIV Therapeutics Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Orbusneich Basic Information List
Table Orbusneich Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orbusneich Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Promed Medical Basic Information List
Table Promed Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promed Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Relisys Medical Basic Information List
Table Relisys Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Relisys Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Reva Medical Basic Information List
Table Reva Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reva Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Sahajanand Basic Information List
Table Sahajanand Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sahajanand Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Sino Medical Basic Information List
Table Sino Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sino Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Sorin Basic Information List
Table Sorin Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sorin Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Terumo Medical Basic Information List
Table Terumo Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Terumo Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Translumina Basic Information List
Table Translumina Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Translumina Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Vascular Concepts Basic Information List
Table Vascular Concepts Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vascular Concepts Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table JW Medical Systems Basic Information List
Table JW Medical Systems Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table JW Medical Systems Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Kinhely Basic Information List
Table Kinhely Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kinhely Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Lepu Medical Basic Information List
Table Lepu Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lepu Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Medfavour Medical Basic Information List
Table Medfavour Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medfavour Medical Drug Eluting Stents (DES) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug Eluting Stents (DES)
Figure Manufacturing Process Analysis of Drug Eluting Stents (DES)
Figure Drug Eluting Stents (DES) Industrial Chain Analysis
Table Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2015
Table Major Buyers of Drug Eluting Stents (DES)
Table Distributors/Traders List
Figure United States Drug Eluting Stents (DES) Production and Growth Rate Forecast (2016-2021)
Figure United States Drug Eluting Stents (DES) Revenue and Growth Rate Forecast (2016-2021)
Table United States Drug Eluting Stents (DES) Production Forecast by Type (2016-2021)
Table United States Drug Eluting Stents (DES) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories